Home › Funds › Western Financial Corp/CA › ARWR
Western Financial Corp/CA position in ARWR
ARROWHEAD PHARMACEUTICALS IN · Health Care
Western Financial Corp/CA reported holding 820,239 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$53.7M, representing 17.87% of its reported portfolio and ranking #1 among its reported holdings. Western Financial Corp/CA has disclosed ARWR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Western Financial Corp/CA's ARWR position evolved
Western Financial Corp/CA first disclosed a stake in ARWR in Q3 2023 at 820,239 shares (US$22.0M). The position peaked in Q2 2026 at 820,239 shares, worth US$66.9M. Across 13 filings, Western Financial Corp/CA held the position steady without any share-count change. The most recent filing (Q3 2026) shows 820,239 shares valued at US$53.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 820.24K | $22.04M | New |
| Q4 2023 | 820.24K | $25.10M | Hold |
| Q1 2024 | 820.24K | $23.46M | Hold |
| Q2 2024 | 820.24K | $21.32M | Hold |
| Q3 2024 | 820.24K | $15.89M | Hold |
| Q4 2024 | 820.24K | $15.42M | Hold |
| Q1 2025 | 820.24K | $10.45M | Hold |
| Q2 2025 | 820.24K | $12.96M | Hold |
| Q3 2025 | 820.24K | $28.29M | Hold |
| Q4 2025 | 820.24K | $54.46M | Hold |
| Q1 2026 | 820.24K | $51.43M | Hold |
| Q2 2026 | 820.24K | $66.86M | Hold |
| Q3 2026 | 820.24K | $53.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARWR and 13F data
ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 52 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARWR
- Avoro Capital Advisors LLC 11.36M sh · $925.59M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 3.30M sh · $269.14M · Q2 2026
- BAKER BROS. ADVISORS LP 1.99M sh · $162.43M · Q2 2026
- Siren, L.L.C. 1.72M sh · $139.83M · Q2 2026
- Vestal Point Capital, LP 1.57M sh · $128.38M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.39M sh · $113.22M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.35M sh · $110.08M · Q2 2026
- Hood River Capital Management LLC 1.12M sh · $91.35M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 830.25K sh · $67.67M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 25.00M sh · $29.94M · Q2 2026
- MACKAY SHIELDS LLC 27.19M sh · $27.84M · Q3 2026
More on Western Financial Corp/CA
FAQ
How long has Western Financial Corp/CA held ARWR?
Western Financial Corp/CA has disclosed ARWR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Western Financial Corp/CA's current position in ARWR?
As of Q3 2026, Western Financial Corp/CA holds 820.24K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $53.68M, representing 17.87% of its reported portfolio and ranking #1.
Has Western Financial Corp/CA been buying or selling ARWR?
In the latest 13F filing (Q3 2026), Western Financial Corp/CA held unchanged its position in ARWR. The position peaked in Q2 2026 at 820.24K shares.
Which other funds hold ARWR?
Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.